APA (7th ed.) Citation

Bossuyt, V., Provenzano, E., Symmans, W. F., Boughey, J. C., Coles, C., Curigliano, G., . . . Cameron, D. (2015). Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Annals of Oncology, 26(7), 1280. https://doi.org/10.1093/annonc/mdv161

Chicago Style (17th ed.) Citation

Bossuyt, V., et al. "Recommendations for Standardized Pathological Characterization of Residual Disease for Neoadjuvant Clinical Trials of Breast Cancer by the BIG-NABCG Collaboration." Annals of Oncology 26, no. 7 (2015): 1280. https://doi.org/10.1093/annonc/mdv161.

MLA (9th ed.) Citation

Bossuyt, V., et al. "Recommendations for Standardized Pathological Characterization of Residual Disease for Neoadjuvant Clinical Trials of Breast Cancer by the BIG-NABCG Collaboration." Annals of Oncology, vol. 26, no. 7, 2015, p. 1280, https://doi.org/10.1093/annonc/mdv161.